Exposure to histone deacetylase inhibitors during Pavlovian conditioning enhances subsequent cue-induced reinstatement of operant behavior

Behavioural Pharmacology

Volumn 24, Issue 3, 2013, Pages 164-171

  Ploense, Kyle L ^a   Kerstetter, Kerry A ^a   Wade, Matthew A ^a   Woodward, Nicholas C ^a   Maliniak, Dan ^a   Reyes, Michael ^a   Uchizono, Russell S ^a   Bredy, Timothy W ^b   Kippin, Tod E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

histone deacetylase inhibitors; learning; rat; reinforcement; reinstatement

Indexed keywords

BUTYRIC ACID; COCAINE; HISTONE DEACETYLASE INHIBITOR; VALPROIC ACID;

ANIMAL MODEL; ARTICLE; ASSOCIATION; CONDITIONING; CONTROLLED STUDY; FEAR; INSTRUMENTAL CONDITIONING; LEARNING; MALE; MOTIVATION; NONHUMAN; PLACE PREFERENCE; RAT; REINFORCEMENT; STIMULUS;

ANALYSIS OF VARIANCE; ANIMALS; BUTYRATES; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTONE DEACETYLASE INHIBITORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; VALPROIC ACID;

EID: 84876959258     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32836104ea     Document Type: Article

References (48)

1. Berger SL (2007). The complex language of chromatin regulation during transcription. Nature 447: 407-412. (Pubitemid 46816746)
2. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P (2008). Decoding the epigenetic language of neuronal plasticity. Neuron 60: 961-974.
3. Bredy TW, Sun YE, Kobor MS (2010). How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol 52: 331-342.
4. Bredy TW, Barad M (2008). The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn Mem 15: 39-45. (Pubitemid 351171604)
5. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M (2007). Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14: 268-276. (Pubitemid 46625629)
6. Cunningham MO, Woodhall GL, Jones RS (2003). Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology 45: 907-917. (Pubitemid 37297916)
7. Day JJ, Sweatt JD (2011). Epigenetic mechanism in cognition. Neuron 70: 813-829.
8. Ehrenkaufer GM, Eichinger DJ, Singh U (2007). Trichostatin A effects on gene expression in the protozoan parasite Entamoeba histolytica. BMC Genomics 8: 216.
9. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH (2007). Recovery of learning and memory is associated with chromatin remodeling. Nature 447: 178-182. (Pubitemid 46763080)
10. Ghaemi SN, Gilmer WS, Goldberg JF, Zablotsky B, Kemp DE, Kelley ME, et al. (2007). Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry 68: 1840-1844.
11. Glass GV, Hopkins KD (1984). Statistical methods in education and psychology. Englewood Cliffs (NJ): Prentice-Hall.
12. Gräff J, Mansuy IM (2008). Epigenetic codes in cognition and behaviour. Behav Brain Res 192: 70-87.
13. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS (2004). Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 641: 1079-1086. (Pubitemid 38176913)
14. Kalda A, Heidmets LT, Shen HY, Zharkovsky A, Chen JF (2007). Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice. Behav Brain Res 181: 76-84. (Pubitemid 46765005)
15. Kelleher RT, Gollub LR (1962). A review of positive conditioned reinforcement. J Exp Anal Behav 5: 543-597.
16. Kim J, Park H, Im JY, Choi WS, Kim HS (2007). Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Anticancer Res 27: 3285-3292. (Pubitemid 47607553)
17. Kruzich PJ, See RE (2001). Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J Neurosci 21: RC155.
18. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, et al. (2005). Chromatin remodeling is a key mechanism underlying cocaineinduced plasticity in striatum. Neuron 48: 303-314. (Pubitemid 41476363)
19. Lattal KM, Barrett RM,Wood MA (2007). Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121: 1125-1131. (Pubitemid 350051316)
20. Levenson JM, Sweatt JD (2006). Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. Cell Mol Life Sci 63: 1009-1016. (Pubitemid 43800770)
21. Levenson JM, O'Riordan KJ, Brown KD, Trinh MA, Molfese DL, Sweatt JD (2004). Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279: 40545-40559. (Pubitemid 39287646)
22. Loscher W, Fisher JE, Nau H, Honack D (1989). Valproic acid in amygdalekindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment. J Pharmacol Exp Ther 250: 1067-1078. (Pubitemid 19246722)
23. Maeshima K, Eltsov M (2008). Packaging the genome: the structure of mitotic chromosomes. J Biochem 143: 145-153. (Pubitemid 351238166)
24. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM,Wood MA (2010). Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 67: 36-43.
25. Mantsch JR, Goeders NE (2000). Effects of cocaine self-administration on plasma corticosterone in rats: relationship to hippocampal type II glucocorticoid receptors. Prog NeuroPsychopharmacol Biol Psychiatry 24: 633-646. (Pubitemid 30419085)
26. Marek R, Coelho CM, Sullivan RK, Baker-Andresen D, Li X, Ratnu V, et al. (2011). Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300. J Neurosci 31: 7486-7491.
27. Meinhold JM, Blake LM, Mini LJ,Welge JA, Schwiers M, Hughes A (2005). Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia. Drugs Aging 22: 615-626. (Pubitemid 41214554)
28. Michaelis M, Doerr HW, Cinatl J Jr. (2007). Valproic acid as anti-cancer drug. Curr Pharm Des 13: 3378-3393. (Pubitemid 350201672)
29. Morris MJ, Karra AS, Monteggia LM (2010). Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav Pharmacol 21: 409-419.
30. McQuown SC, Wood MA (2011). HDAC3 and the molecular brake pad hypothesis. Neurobiol Learn Mem 96: 27-34.
31. Mu P, Yu LC (2007). Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. Neurosc Lett 426: 135-138. (Pubitemid 47498719)
32. Mutschler HN, Miczek KA (1998). Withdrawal from a self-administered or noncontingent cocaine binge: differences in ultrasonic distress vocalizations in rats. Psychopharmacology 135: 161-168.
33. Provenzano MJ, Fitzgerald MP, Krager K, Domann FE (2007). Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). Otolaryngology Head Neck Surg 137: 722-728. (Pubitemid 47632934)
34. Renthal W, Maze I, Krishnan V, Covington HE 3rd, Xiao G, Kumar A, et al. (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56: 517-529. (Pubitemid 350030878)
35. Rescorla RA (1967). Pavlovian conditioning and its proper control procedures. Psychol Rev 74: 71-80.
36. Rescorla RA (1988). Behavioral studies of Pavlovian conditioning. Ann Rev Neurosci 11: 329-352.
37. Rescorla RA (2000). Associative changes with a random CS-US relationship. Q J Exp Psychol B 53: 325-340.
38. Reynolds MF, Sisk EC, Rasgon NL (2007). Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Curr Med Chem 14: 2799-2812. (Pubitemid 350138960)
39. Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug selfadministration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11. (Pubitemid 26180064)
40. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008). Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28: 9342-9348.
41. Sanchis-Segura C, Lopez-Atalaya JP, Barco A (2009). Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 34: 2642-2654.
42. Stefanko DP, Barrett RM, Ly AR, Reolon GK, Wood MA (2009). Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci USA 106: 9447-9452.
43. Sun J,Wang L, Jiang B, Hui B, Lv Z, Ma L (2008). The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine-and sucrose-maintained self-administration in rats. Neurosci Lett 441: 72-76.
44. Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, et al. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99: 17095-17100. (Pubitemid 36034104)
45. Tulloch IF, Walter DS, Howe GM, Howe SJ (1982). The relationship between plasma concentration of valproic acid and its anticonvulsant and behavioural effects in the rat. Neuropharmacology 21: 555-562. (Pubitemid 12038802)
46. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, et al. (2007). Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. J Neurosci 27: 6128-6140. (Pubitemid 46890024)
47. Wang R, Zhang Y, Qing H, Liu M, Yang P (2010a). The extinction of morphineinduced conditioned place preference by histone deacetylase inhibition. Neurosci Lett 483: 137-142.
48. Wang L, Lv Z, Hu Z, Sheng J, Hui B, Sun J, Ma L (2010b). Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. Neuropsychopharmacology 35: 913-928.